Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for Comorbid Opioid Addiction and Chronic Pain
NCT05076370Phase 1Completed
- Sponsor
- Yale University
- Start
- Dec 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of cannabidiol in opioid use disorder (OUD) and chronic pain (4 arms), sponsored by Yale University. Primary endpoints: Agitation Calmness Evaluation Scale, Mini Mental Status Examination and 1 more. Started Dec 2021; status: completed.
02
Drugs
cannabidiol
03
Conditions
opioid use disorder (OUD)chronic pain
Beyond the preview
Go deeper on NCT05076370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05076370.